1
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Analysis of the in vitro lymphoproliferative responses and antibody levels to the arc-5 antigen in patients with cystic hydatid disease

, , , &
Pages 621-629 | Received 18 Jun 1990, Accepted 03 Aug 1992, Published online: 15 Nov 2016
 

Abstract

Using a commercially-available, purified, arc-5 antigen, we examined the in vitro proliferative responses of peripheral blood mononuclear cells from hydatid patients and from healthy controls. Antibody levels of different immunoglobulin classes were also measured against the same antigen, in sera of both groups. Our findings indicate that lymphocytes from healthy controls do not proliferate to the arc-5 antigen, whereas lymphocytes from the majority of patients do. The negative or weak responses observed among a few patients were not due either to increased release of prostaglandins in culture or to a lack of responsiveness to Interleukin-2. Antibodies of all three classes, G, M and A, measured by an ELISA, were elevated in sera of patients when compared with controls. However, only levels of specific IgG antibodies gave an excellent discrimination of the disease state and these were of diagnostic value. No direct or inverse correlations between lymphoproliferative responses and antibody levels were observed in either group, although a few patients with relatively low antibody titres demonstrated very high proliferative responses. The possible use of the proliferative assay as an adjunct to serology in the diagnosis of hydatid disease is indicated.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.